Showing results (21-30 of 172) with videos related to

Sort By:
Pageof 18
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with HypertensionGwenolé Loas, Philippe Van de Borne, Gil Darquennes, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 19, 2012
Factors influencing differences between invasive and spontaneous baroreflex estimates: distinct methods or different data?Sónia Gouveia, Ana Paula Rocha, Philippe van de Borne, et al.
Acta Cardiologica|February 9, 2016
The COMmon control of hypErtenSion and Therapeutic Attitudes in Belgium and Luxemburg study (COME STAI)Philippe van de Borne, Luc Missault, Alexandre Persu, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|January 28, 2010
Acute cardiovascular response to resistance training during cardiac rehabilitation: effect of repetition speed and rest periodsMichel Lamotte, Fany Fleury, Melissa Pirard, et al.
Healthcare (Basel, Switzerland)|October 27, 2022
Benefits of Cardio-Pulmonary Rehabilitation in Moderate to Severe Forms of COVID-19 InfectionClara Douin, Kevin Forton, Michel Lamotte, et al.
European Heart Journal. Case Reports|October 15, 2025
Failure of oral anti-Xa to prevent non-bacterial thrombotic endocarditis in cancer: case report and literature reviewMariam Benjelloun, Edith Jottrand, Emmanuel Joly, et al.
Journal of the American College of Cardiology|November 11, 2003
Peripheral sympathetic control during dobutamine infusion: effects of aging and heart failureSonia Velez-Roa, Marc Renard, Jean-Paul Degaute, et al.
Acta Cardiologica|January 11, 2020
Summary of 2019 ESC Guidelines on chronic coronary syndromes, acute pulmonary embolism, supraventricular tachycardia and dislipidaemiasMarc J Claeys, Yves Vandekerckhove, Bernard Cosyns, et al.
British Journal of Clinical Pharmacology|August 29, 2006
Dose-dependent effect of dobutamine on chemoreflex activity in healthy volunteersAtul Pathak, Sonia Velez-Roa, Olivier Xhaët, et al.
Pageof 18